Home >Companies >Company-results >GSK Pharma Q2 profit down 23% to ₹101 crore
Shares of GSK Pharma were trading at ₹1,379.30 per scrip on BSE, down 3.11% from the previous close.
Shares of GSK Pharma were trading at ₹1,379.30 per scrip on BSE, down 3.11% from the previous close.

GSK Pharma Q2 profit down 23% to ₹101 crore

GSK Pharma’s total income stood at ₹831.13 crore for the second quarter. It was ₹845.89 crore in the second quarter of 2017-18

New Delhi: GlaxoSmithKline (GSK)Pharmaceuticals on Monday reported 22.67% fall in standalone net profit to 100.77 crore for the quarter ended 30 September 2018.

The company had posted a net profit of 130.32 crore in the year-ago period, GSK Pharma said in a BSE filing.

Total income of the company stood at 831.13 crore for the reported quarter. It was 845.89 crore in the second quarter of 2017-18.

Shares of GSK Pharma were trading at 1,379.30 per scrip on BSE, down 3.11% from the previous close.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Click here to read the Mint ePapermint is now on Telegram. Join mint channel in your Telegram and stay updated

Close
×
My Reads Redeem a Gift Card Logout